Cutler Group LP Crispr Therapeutics Ag Put Options Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Oct 25, 2022	SELL	$61.1 - $83.78 $513,240 - $703,752	-8,400 Reduced 42.86%	11,200 $474,000
Q2 2022 Aug 04, 2022	SELL	$43.23 - $73.83 $354,486 - $605,406	-8,200 Reduced 29.5%	19,600 $639,000
Q1 2022 Apr 14, 2022	SELL	$53.19 - $79.24 $569,133 - $847,868	-10,700 Reduced 27.79%	27,800 $1.01 Million
Q4 2021 Jan 18, 2022	BUY	$70.09 - $111.29 $1.6 Million - $2.54 Million	22,800 Added 145.22%	38,500 $1.19 Million
Q3 2021 Oct 26, 2021	SELL	$110.2 - $156.64 $22,040 - $31,327	-200 Reduced 1.26%	15,700 $623,000
Q2 2021 Jul 19, 2021	BUY	$100.84 - $161.89 $413,444 - $663,749	4,100 Added 34.75%	15,900 $476,000
Q1 2021 Apr 26, 2021	BUY	$110.72 - $210.04 $132,864 - $252,048	1,200 Added 11.32%	11,800 $587,000
Q4 2020 Jan 21, 2021	BUY	$79.67 - $173.23 $772,799 - $1.68 Million	9,700 Added 1077.78%	10,600 $352,000
Q3 2020 Oct 27, 2020	BUY	$78.5 - $100.64 $31,400 - $40,256	400 Added 80.0%	900 $12,000
Q4 2018 Feb 05, 2019	SELL	$22.73 - $42.34 $59,098 - $110,084	-2,600 Reduced 83.87%	500 $9,000
Q3 2018 Nov 07, 2018	BUY	$44.35 - $65.71 $39,915 - $59,138	900 Added 40.91%	3,100 $33,000
Q2 2018 Aug 10, 2018	SELL	$42.62 - $73.59 $234,410 - $404,745	-5,500 Reduced 71.43%	2,200 $2,000
Q1 2018 May 11, 2018	BUY	$23.52 - $58.17 $134,064 - $331,569	5,700 Added 285.0%	7,700 $15,000
Q4 2017 Jan 17, 2018	SELL	$16.95 - $23.48 $45,765 - $63,396	-2,700 Reduced 57.45%	2,000 $0
Q3 2017 Oct 17, 2017	BUY	$16.75 - $20.66 $78,725 - $97,102	4,700	4,700 $4,000

523

58M

1.73M

1.84M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.87B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.